PeptideDB

TCN 213 556803-08-8

TCN 213 556803-08-8

CAS No.: 556803-08-8

TCN 213 is a selective, surmountable, glycine-dependent GluN1/GluN2A NMDAR antagonist (inhibitor) with IC50s of 0.55, 3.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

TCN 213 is a selective, surmountable, glycine-dependent GluN1/GluN2A NMDAR antagonist (inhibitor) with IC50s of 0.55, 3.5, and 40 μM in the presence of 75, 750, and 7500 nM glycine, respectively. TCN 213 may be utilized to pharmacologically monitor the switching of NMDAR expression in developing cortical neurons.

Physicochemical Properties


Molecular Formula C18H24N4OS2
Molecular Weight 376.54
Exact Mass 376.139
CAS # 556803-08-8
PubChem CID 2608149
Appearance White to off-white solid powder
LogP 4.201
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 8
Heavy Atom Count 25
Complexity 401
Defined Atom Stereocenter Count 0
InChi Key XBAZPYFIYYCZBO-UHFFFAOYSA-N
InChi Code

InChI=1S/C18H24N4OS2/c23-16(19-11-14-7-3-1-4-8-14)13-24-18-22-21-17(25-18)20-12-15-9-5-2-6-10-15/h2,5-6,9-10,14H,1,3-4,7-8,11-13H2,(H,19,23)(H,20,21)
Chemical Name

2-[[5-(benzylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(cyclohexylmethyl)acetamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets GluN1/GluN2A NMDAR 0.55-40 μM (IC50)
ln Vitro NMDA-evoked currents in neurons transfected with GluN2A subunits are inhibited by TCN 213 (30 µM)[1].
References

[1]. “Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.” British journal of pharmacology vol. 166,3 (2012): 924-37.

[2]. TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner. Neuropharmacology. 2012 Sep;63(3):441-9.


Solubility Data


Solubility (In Vitro) DMSO: 250 mg/mL (663.94 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (5.52 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6558 mL 13.2788 mL 26.5576 mL
5 mM 0.5312 mL 2.6558 mL 5.3115 mL
10 mM 0.2656 mL 1.3279 mL 2.6558 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.